NEW YORK, July 31- Nanogen turned in a slight increase in revenues and a significant increase in losses during its second quarter, the company said Tuesday.

The company posted revenues for the most recent financial period of $2.7 million, up slightly from the $2.4 million in the second quarter last year. Nanogen attributed their revenue rise to sponsored research programs from the company's corporate alliances, contracts and grants with government agencies, and, to a lesser extent, sales of its NanoChip Molecular Biology Workstations and cartridges.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.